Serum BMP-2 and BMP-4 levels and their relationship with disease activity in patients with rheumatoid arthritis and ankylosing spondylitis.
Ali Erhan OzdemirelSerdar Can GüvenZühre Sarı SürmelİAyla ÖzyuvalıMehmet KurtDiana RüstemovaAyşe Peyman Yalçın SayanHüseyin TutkanŞebnem AtamanPublished in: Archives of rheumatology (2022)
Our study results suggest that the BMP pathway may have different dual effects in AS and RA patients depending on the underlying pathogenesis, and that local effects are more prominent than serum levels.
Keyphrases
- ankylosing spondylitis
- disease activity
- rheumatoid arthritis
- systemic lupus erythematosus
- mesenchymal stem cells
- rheumatoid arthritis patients
- juvenile idiopathic arthritis
- end stage renal disease
- newly diagnosed
- ejection fraction
- bone regeneration
- prognostic factors
- peritoneal dialysis
- bone marrow
- idiopathic pulmonary fibrosis
- patient reported